SOHONOS
Identification of Sohonos
No description |
Google image searchProduct monograph
Active ingredient
palovarotene, 2.5 MG
DIN: 02524643
Dosage form(s): CAPSULE
Route(s) of administration: ORAL
Schedule: Prescription
Company: IPSEN BIOPHARMACEUTICALS CANADA INC
Date: 20-JUN-2022
ATC:
- M09 — OTHER DRUGS FOR DISORDERS OF THE MUSCULOSKELETAL SYSTEM (ATC, ATC/DDD, )
- M09A — OTHER DRUGS FOR DISORDERS OF THE MUSCULOSKELETAL SYSTEM (ATC, ATC/DDD)
- M09AX — Other drugs for disorders of the musculo-skeletal system (ATC, ATC/DDD)
- M09AX11 — PALOVAROTENE (ATC/DDD)